AAAAAA

   
Results: 1-9 |
Results: 9
Establishment of complete and mixed donor chimerism after allogeneic lymphohematopoietic transplantation: Recommendations from a Workshop at the 2001Tandem Meetings
Authors: Antin, JH Childs, R Filipovich, AH Giralt, S Mackinnon, S Spitzer, T Weisdorf, D
Citation: Jh. Antin et al., Establishment of complete and mixed donor chimerism after allogeneic lymphohematopoietic transplantation: Recommendations from a Workshop at the 2001Tandem Meetings, BIOL BLOOD, 7(9), 2001, pp. 473-485
The effect of graft purging with 4-hydroperoxycyclophosphamide in autologous bone marrow transplantation for acute myelogenous leukemia
Authors: Miller, CB Rowlings, PA Zhang, MJ Jones, RJ Piantadosi, S Keating, A Armitage, JO Calderwood, S Harris, RE Klein, JP Lazarus, HM Linker, CA Sobocinski, KA Weisdorf, D Horowitz, MM
Citation: Cb. Miller et al., The effect of graft purging with 4-hydroperoxycyclophosphamide in autologous bone marrow transplantation for acute myelogenous leukemia, EXP HEMATOL, 29(11), 2001, pp. 1336-1346
Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors: the effect of donor age
Authors: Kollman, C Howe, CWS Anasetti, C Antin, JH Davies, SM Filipovich, AH Hegland, J Kamani, N Kernan, NA King, R Ratanatharathorn, V Weisdorf, D Confer, DL
Citation: C. Kollman et al., Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors: the effect of donor age, BLOOD, 98(7), 2001, pp. 2043-2051
Effect of BLA class II gene disparity on clinical outcome in unrelated donor hematopoietic cell transplantation for chronic myeloid leukemia: the US National Marrow Donor Program Experience
Authors: Petersdorf, EW Kollman, C Hurley, CK Dupont, B Nademanee, A Begovich, AB Weisdorf, D McGlave, P
Citation: Ew. Petersdorf et al., Effect of BLA class II gene disparity on clinical outcome in unrelated donor hematopoietic cell transplantation for chronic myeloid leukemia: the US National Marrow Donor Program Experience, BLOOD, 98(10), 2001, pp. 2922-2929
A randomized trial comparing prednisone with antithymocyte globulin/prednisone as an initial systemic therapy for moderately severe acute graft-versus-host disease
Authors: Cragg, L Blazar, BR Defor, T Kolatker, N Miller, W Kersey, J Ramsay, N McGlave, P Filipovich, A Weisdorf, D
Citation: L. Cragg et al., A randomized trial comparing prednisone with antithymocyte globulin/prednisone as an initial systemic therapy for moderately severe acute graft-versus-host disease, BIOL BLOOD, 6(4A), 2000, pp. 441-447
Origins of circulating endothelial cells and endothelial outgrowth from blood
Authors: Lin, Y Weisdorf, D Solovey, A Hebbel, RP
Citation: Y. Lin et al., Origins of circulating endothelial cells and endothelial outgrowth from blood, J CLIN INV, 105(1), 2000, pp. 71-77
Effect of postremission chemotherapy before human leukocyte antigen-identical sibling transplantation for acute myelogenous leukemia in first complete remission
Authors: Tallman, MS Rowlings, PA Milone, G Zhang, MJ Perez, WS Weisdorf, D Keating, A Gale, RP Geller, RB Laughlin, MJ Lazarus, HM Luger, SM McCarthy, PL Rowe, JM Saez, RA Vowels, MR Horowitz, MM
Citation: Ms. Tallman et al., Effect of postremission chemotherapy before human leukocyte antigen-identical sibling transplantation for acute myelogenous leukemia in first complete remission, BLOOD, 96(4), 2000, pp. 1254-1258
Long-term survival and late deaths after allogeneic bone marrow transplantation
Authors: Socie, G Stone, JV Wingard, JR Weisdorf, D Henslee-Downey, PJ Bredeson, C Cahn, JY Passweg, JR Rowlings, PA Schouten, HC Kolb, HJ Klein, JP
Citation: G. Socie et al., Long-term survival and late deaths after allogeneic bone marrow transplantation, N ENG J MED, 341(1), 1999, pp. 14-21
Typical and atypical mycobacterium
Authors: Roy, V Weisdorf, D
Citation: V. Roy et D. Weisdorf, Typical and atypical mycobacterium, TRANSPLANT INFECTIONS, 1998, pp. 195-201
Risultati: 1-9 |